These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23198031)

  • 1. Malignant hyperthermia.
    Kim DC
    Korean J Anesthesiol; 2012 Nov; 63(5):391-401. PubMed ID: 23198031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hyperthermia.
    Rosenberg H; Davis M; James D; Pollock N; Stowell K
    Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia: a review.
    Rosenberg H; Pollock N; Schiemann A; Bulger T; Stowell K
    Orphanet J Rare Dis; 2015 Aug; 10():93. PubMed ID: 26238698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current status of malignant hyperthermia.
    Yang L; Tautz T; Zhang S; Fomina A; Liu H
    J Biomed Res; 2019 May; 34(2):75-85. PubMed ID: 32305961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia.
    Ali SZ; Taguchi A; Rosenberg H
    Best Pract Res Clin Anaesthesiol; 2003 Dec; 17(4):519-33. PubMed ID: 14661655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1).
    Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K
    Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant Hyperthermia Susceptibility and Fitness for Duty.
    Lee MA; McGlinch EB; McGlinch MC; Capacchione JF
    Mil Med; 2017 Mar; 182(3):e1854-e1857. PubMed ID: 28290972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia: update on susceptibility testing.
    Litman RS; Rosenberg H
    JAMA; 2005 Jun; 293(23):2918-24. PubMed ID: 15956637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
    Monnier N; Lunardi J
    Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthetic experience for patients with malignant hyperthermia susceptibility determined by molecular genetic test: A report of 2 cases.
    Lee JW; Yi JS; Lee JR; Kim DC
    Korean J Anesthesiol; 2009 Sep; 57(3):387-391. PubMed ID: 30625893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant Hyperthermia - Update on Pathophysiology, Diagnostics and Treatment].
    Johannsen S; Schuster F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):527-537. PubMed ID: 31525786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant Hyperthermia.
    Kaur H; Katyal N; Yelam A; Kumar K; Srivastava H; Govindarajan R
    Mo Med; 2019; 116(2):154-159. PubMed ID: 31040503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant Hyperthermia in Bariatric Surgery: A Case Study With Clinical, Pathophysiological, Biochemical and Biophysical Correlations.
    Oliveira PEA; Salvador GHM; Marchi-Salvador DP
    J Med Cases; 2020 Dec; 11(12):379-387. PubMed ID: 34434350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.
    Galli L; Orrico A; Lorenzini S; Censini S; Falciani M; Covacci A; Tegazzin V; Sorrentino V
    Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia.
    Beam TA; Loudermilk EF; Kisor DF
    Physiol Genomics; 2017 Feb; 49(2):81-87. PubMed ID: 28011884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant hyperthermia].
    Urwyler A; Hartung E
    Anaesthesist; 1994 Aug; 43(8):557-69. PubMed ID: 7978181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
    Brown RL; Pollock AN; Couchman KG; Hodges M; Hutchinson DO; Waaka R; Lynch P; McCarthy TV; Stowell KM
    Hum Mol Genet; 2000 Jun; 9(10):1515-24. PubMed ID: 10888602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1.
    Sudbrak R; Procaccio V; Klausnitzer M; Curran JL; Monsieurs K; van Broeckhoven C; Ellis R; Heyetens L; Hartung EJ; Kozak-Ribbens G
    Am J Hum Genet; 1995 Mar; 56(3):684-91. PubMed ID: 7887423
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.